The diagnostic testing market would grow at a CAGR of 8.63% over the predicted time frame. The market is expected to increase in value from US$ 179.87 Bn in 2022 to US$ 348.75 Bn in 2030.
The on diagnostic testing Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/1984
Report Scope of the Diagnostic Testing Market
| Report Coverage | Details |
| Market Size in 2022 | USD 179.87 Billion |
| Market Size by 2030 | USD 348.75 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 8.63% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Type, Application, Approach, Solution, Technology, Mode of Testing, Sample Type, Testing Type, Age, Distribution Channel, End User, Geography |
A recent report provides crucial insights along with application based and forecast information in the Global Diagnostic testing Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Diagnostic testing market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Diagnostic testing market are included as given below:
Diagnostic testing Market Key Players
- F-Hoffman La-Rcohe Ltd. (Switzerland)
- Danaher (US)
- BD (US)
- Thermo Fisher Scientific Inc. (US)
- ACON Laboratories Inc. (US)
- Hemosure, Inc. (US)
- MicroGen Diagnostics (US)
- Grifols, S.A (Spain)
- BODITECH MED INC. (South Korea)
- Chembio Diagnostic Systems, Inc. (US)
- Nanoentek (South Korea)
- DiaSorin S.p.A. (Italy)
- Bio-Rad Laboratories, Inc. (US)
- BIOMEDOMICS INC (US)
- EKF Diagnostics Holdings plc (UK)
- Siemens Healthcare GmbH (Germany)
- PerkinElmer Inc. (US)
- bioMérieux SA (France)
- ARKRAY USA, Inc. (US)
- Biohit Oyj (Finland)
- Quidel Corporation (US)
- Illumina, Inc. (US)
- Lamdagen Corporation (US)
- LifeSign LLC. (US)
- Medixbiochemica (Finaland)
- Nova Biomedical (US)
- Ortho Clinical Diagnostics (US)
- Sannuo Biosensing Co., Ltd. (US)
- STRECK (US)
- Sysmex Corporation (Japan)
Market Segments
By Type
- Clinical Diagnostic
- Home Diagnostic
By Application
- Cardiology
- Oncology
- Neurology
- Orthopedics
- Gastroenterology
- Gynecology
- Odontology
- Others
By Approach
- Molecular Diagnostic Instrument
- In-Vitro Diagnostic Instrument
- Point Of Care Testing Instrument
By Solution
- Services
- Products
By Technology
- Immunoassay-Based
- PCR-Based
- Next-generation Sequencing
- Spectroscopy-Based
- Chromatography-Based
- Microfluidics
- Substrate Technology
- Others
By Mode of Testing
- Prescription Based Testing
- OTC Testing
By Sample Type
- Urine
- Saliva
- Blood
- Hair
- Sweat
- Others
By Testing Type
- Biochemistry
- Hematology
- Microbiology
- Histopathology
- Others
By Age
- Pediatric
- Adult & Geriatric
By Distribution Channel
- Direct Tenders
- Retail Sales
- Online Sales
By End User
- Hospitals, Diagnostic Center
- Research Labs and Institutes
- Research Institute
- Homecare
- Blood Banks
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Report Objectives
- To define, describe, and forecast the global diagnostic testing market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the diagnostic testing market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Ages
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Eleven Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Diagnostic Testing Market, By Type
7.1. Diagnostic Testing Market, by Type, 2022-2030
7.1.1. Clinical Diagnostic
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Home Diagnostic
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Diagnostic Testing Market, By Application
8.1. Diagnostic Testing Market, by Application, 2022-2030
8.1.1. Cardiology
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Oncology
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Neurology
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Orthopedics
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Gastroenterology
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Gynecology
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Odontology
8.1.8.1. Market Revenue and Forecast (2017-2030)
8.1.9. Others
8.1.9.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Diagnostic Testing Market, By Approach
9.1. Diagnostic Testing Market, by Approach, 2022-2030
9.1.1. Molecular Diagnostic Instrument
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. In-Vitro Diagnostic Instrument
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Point Of Care Testing Instrument
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Diagnostic Testing Market, By Solution
10.1. Diagnostic Testing Market, by Solution, 2022-2030
10.1.1. Services
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Products
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Diagnostic Testing Market, By Technology
11.1. Diagnostic Testing Market, by Technology, 2022-2030
11.1.1. Immunoassay-Based
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. PCR-Based
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Next-generation Sequencing
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Spectroscopy-Based
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Chromatography-Based
11.1.5.1. Market Revenue and Forecast (2017-2030)
11.1.6. Microfluidics
11.1.6.1. Market Revenue and Forecast (2017-2030)
11.1.7. Substrate Technology
11.1.7.1. Market Revenue and Forecast (2017-2030)
11.1.8. Others
11.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Diagnostic Testing Market, By Mode of Testing
12.1. Diagnostic Testing Market, by Mode of Testing, 2022-2030
12.1.1. Prescription Based Testing
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. OTC Testing
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Diagnostic Testing Market, By Sample Type
13.1. Diagnostic Testing Market, by Sample Type, 2022-2030
13.1.1. Urine
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Saliva
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.3. Blood
13.1.3.1. Market Revenue and Forecast (2017-2030)
13.1.4. Hair
13.1.4.1. Market Revenue and Forecast (2017-2030)
13.1.5. Sweat
13.1.5.1. Market Revenue and Forecast (2017-2030)
13.1.6. Others
13.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Diagnostic Testing Market, By Testing Type
14.1. Diagnostic Testing Market, by Testing Type, 2022-2030
14.1.1. Biochemistry
14.1.1.1. Market Revenue and Forecast (2017-2030)
14.1.2. Hematology
14.1.2.1. Market Revenue and Forecast (2017-2030)
14.1.3. Microbiology
14.1.3.1. Market Revenue and Forecast (2017-2030)
14.1.4. Histopathology
14.1.4.1. Market Revenue and Forecast (2017-2030)
14.1.5. Others
14.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 15. Global Diagnostic Testing Market, By Age
15.1. Diagnostic Testing Market, by Age, 2022-2030
15.1.1. Pediatric
15.1.1.1. Market Revenue and Forecast (2017-2030)
15.1.2. Adult & Geriatric
15.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 16. Global Diagnostic Testing Market, By Distribution Channel
16.1. Diagnostic Testing Market, by Distribution Channel, 2022-2030
16.1.1. Direct Tenders
16.1.1.1. Market Revenue and Forecast (2017-2030)
16.1.2. Retail Sales
16.1.2.1. Market Revenue and Forecast (2017-2030)
16.1.3. Online Sales
16.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 17. Global Diagnostic Testing Market, By End User
17.1. Diagnostic Testing Market, by End User, 2022-2030
17.1.1. Hospitals, Diagnostic Center
17.1.1.1. Market Revenue and Forecast (2017-2030)
17.1.2. Research Labs and Institutes
17.1.2.1. Market Revenue and Forecast (2017-2030)
17.1.3. Research Institute
17.1.3.1. Market Revenue and Forecast (2017-2030)
17.1.4. Homecare
17.1.4.1. Market Revenue and Forecast (2017-2030)
17.1.5. Blood Banks
17.1.5.1. Market Revenue and Forecast (2017-2030)
17.1.6. Specialty Clinics
17.1.6.1. Market Revenue and Forecast (2017-2030)
17.1.7. Ambulatory Surgical Centers
17.1.7.1. Market Revenue and Forecast (2017-2030)
17.1.8. Others
17.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 18. Global Diagnostic Testing Market, Regional Estimates and Trend Forecast
18.1. North America
18.1.1. Market Revenue and Forecast, by Type (2017-2030)
18.1.2. Market Revenue and Forecast, by Application (2017-2030)
18.1.3. Market Revenue and Forecast, by Approach (2017-2030)
18.1.4. Market Revenue and Forecast, by Solution (2017-2030)
18.1.5. Market Revenue and Forecast, by Technology (2017-2030)
18.1.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.1.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.1.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.1.9. Market Revenue and Forecast, by Age (2017-2030)
18.1.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.1.11. Market Revenue and Forecast, by End User (2017-2030)
18.1.12. U.S.
18.1.12.1. Market Revenue and Forecast, by Type (2017-2030)
18.1.12.2. Market Revenue and Forecast, by Application (2017-2030)
18.1.12.3. Market Revenue and Forecast, by Approach (2017-2030)
18.1.12.4. Market Revenue and Forecast, by Solution (2017-2030)
18.1.12.5. Market Revenue and Forecast, by Technology (2017-2030)
18.1.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.1.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.1.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.1.12.9. Market Revenue and Forecast, by Age (2017-2030)
18.1.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.1.12.11. Market Revenue and Forecast, by End User (2017-2030)
18.1.12.12. Market Revenue and Forecast, by December (2017-2030)
18.1.12.13. Market Revenue and Forecast, by Eleven (2017-2030)
18.1.13. Rest of North America
18.1.13.1. Market Revenue and Forecast, by Type (2017-2030)
18.1.13.2. Market Revenue and Forecast, by Application (2017-2030)
18.1.13.3. Market Revenue and Forecast, by Approach (2017-2030)
18.1.13.4. Market Revenue and Forecast, by Solution (2017-2030)
18.1.13.5. Market Revenue and Forecast, by Technology (2017-2030)
18.1.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.1.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.1.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.1.13.9. Market Revenue and Forecast, by Age (2017-2030)
18.1.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.1.13.11. Market Revenue and Forecast, by End User (2017-2030)
18.2. Europe
18.2.1. Market Revenue and Forecast, by Type (2017-2030)
18.2.2. Market Revenue and Forecast, by Application (2017-2030)
18.2.3. Market Revenue and Forecast, by Approach (2017-2030)
18.2.4. Market Revenue and Forecast, by Solution (2017-2030)
18.2.5. Market Revenue and Forecast, by Technology (2017-2030)
18.2.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.2.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.2.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.2.9. Market Revenue and Forecast, by Age (2017-2030)
18.2.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.2.11. Market Revenue and Forecast, by End User (2017-2030)
18.2.12. UK
18.2.12.1. Market Revenue and Forecast, by Type (2017-2030)
18.2.12.2. Market Revenue and Forecast, by Application (2017-2030)
18.2.12.3. Market Revenue and Forecast, by Approach (2017-2030)
18.2.12.4. Market Revenue and Forecast, by Solution (2017-2030)
18.2.12.5. Market Revenue and Forecast, by Technology (2017-2030)
18.2.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.2.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.2.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.2.12.9. Market Revenue and Forecast, by Age (2017-2030)
18.2.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.2.12.11. Market Revenue and Forecast, by End User (2017-2030)
18.2.13. Germany
18.2.13.1. Market Revenue and Forecast, by Type (2017-2030)
18.2.13.2. Market Revenue and Forecast, by Application (2017-2030)
18.2.13.3. Market Revenue and Forecast, by Approach (2017-2030)
18.2.13.4. Market Revenue and Forecast, by Solution (2017-2030)
18.2.13.5. Market Revenue and Forecast, by Technology (2017-2030)
18.2.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.2.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.2.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.2.13.9. Market Revenue and Forecast, by Age (2017-2030)
18.2.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.2.13.11. Market Revenue and Forecast, by End User (2017-2030)
18.2.14. France
18.2.14.1. Market Revenue and Forecast, by Type (2017-2030)
18.2.14.2. Market Revenue and Forecast, by Application (2017-2030)
18.2.14.3. Market Revenue and Forecast, by Approach (2017-2030)
18.2.14.4. Market Revenue and Forecast, by Solution (2017-2030)
18.2.14.5. Market Revenue and Forecast, by Technology (2017-2030)
18.2.14.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.2.14.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.2.14.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.2.14.9. Market Revenue and Forecast, by Age (2017-2030)
18.2.14.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.2.14.11. Market Revenue and Forecast, by End User (2017-2030)
18.2.15. Rest of Europe
18.2.15.1. Market Revenue and Forecast, by Type (2017-2030)
18.2.15.2. Market Revenue and Forecast, by Application (2017-2030)
18.2.15.3. Market Revenue and Forecast, by Approach (2017-2030)
18.2.15.4. Market Revenue and Forecast, by Solution (2017-2030)
18.2.15.5. Market Revenue and Forecast, by Technology (2017-2030)
18.2.15.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.2.15.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.2.15.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.2.15.9. Market Revenue and Forecast, by Age (2017-2030)
18.2.15.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.2.15.11. Market Revenue and Forecast, by End User (2017-2030)
18.3. APAC
18.3.1. Market Revenue and Forecast, by Type (2017-2030)
18.3.2. Market Revenue and Forecast, by Application (2017-2030)
18.3.3. Market Revenue and Forecast, by Approach (2017-2030)
18.3.4. Market Revenue and Forecast, by Solution (2017-2030)
18.3.5. Market Revenue and Forecast, by Technology (2017-2030)
18.3.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.3.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.3.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.3.9. Market Revenue and Forecast, by Age (2017-2030)
18.3.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.3.11. Market Revenue and Forecast, by End User (2017-2030)
18.3.12. India
18.3.12.1. Market Revenue and Forecast, by Type (2017-2030)
18.3.12.2. Market Revenue and Forecast, by Application (2017-2030)
18.3.12.3. Market Revenue and Forecast, by Approach (2017-2030)
18.3.12.4. Market Revenue and Forecast, by Solution (2017-2030)
18.3.12.5. Market Revenue and Forecast, by Technology (2017-2030)
18.3.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.3.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.3.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.3.12.9. Market Revenue and Forecast, by Age (2017-2030)
18.3.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.3.12.11. Market Revenue and Forecast, by End User (2017-2030)
18.3.13. China
18.3.13.1. Market Revenue and Forecast, by Type (2017-2030)
18.3.13.2. Market Revenue and Forecast, by Application (2017-2030)
18.3.13.3. Market Revenue and Forecast, by Approach (2017-2030)
18.3.13.4. Market Revenue and Forecast, by Solution (2017-2030)
18.3.13.5. Market Revenue and Forecast, by Technology (2017-2030)
18.3.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.3.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.3.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.3.13.9. Market Revenue and Forecast, by Age (2017-2030)
18.3.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.3.13.11. Market Revenue and Forecast, by End User (2017-2030)
18.3.14. Japan
18.3.14.1. Market Revenue and Forecast, by Type (2017-2030)
18.3.14.2. Market Revenue and Forecast, by Application (2017-2030)
18.3.14.3. Market Revenue and Forecast, by Approach (2017-2030)
18.3.14.4. Market Revenue and Forecast, by Solution (2017-2030)
18.3.14.5. Market Revenue and Forecast, by Technology (2017-2030)
18.3.14.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.3.14.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.3.14.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.3.14.9. Market Revenue and Forecast, by Age (2017-2030)
18.3.14.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.3.14.11. Market Revenue and Forecast, by End User (2017-2030)
18.3.15. Rest of APAC
18.3.15.1. Market Revenue and Forecast, by Type (2017-2030)
18.3.15.2. Market Revenue and Forecast, by Application (2017-2030)
18.3.15.3. Market Revenue and Forecast, by Approach (2017-2030)
18.3.15.4. Market Revenue and Forecast, by Solution (2017-2030)
18.3.15.5. Market Revenue and Forecast, by Technology (2017-2030)
18.3.15.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.3.15.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.3.15.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.3.15.9. Market Revenue and Forecast, by Age (2017-2030)
18.3.15.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.3.15.11. Market Revenue and Forecast, by End User (2017-2030)
18.4. MEA
18.4.1. Market Revenue and Forecast, by Type (2017-2030)
18.4.2. Market Revenue and Forecast, by Application (2017-2030)
18.4.3. Market Revenue and Forecast, by Approach (2017-2030)
18.4.4. Market Revenue and Forecast, by Solution (2017-2030)
18.4.5. Market Revenue and Forecast, by Technology (2017-2030)
18.4.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.4.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.4.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.4.9. Market Revenue and Forecast, by Age (2017-2030)
18.4.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.4.11. Market Revenue and Forecast, by End User (2017-2030)
18.4.12. GCC
18.4.12.1. Market Revenue and Forecast, by Type (2017-2030)
18.4.12.2. Market Revenue and Forecast, by Application (2017-2030)
18.4.12.3. Market Revenue and Forecast, by Approach (2017-2030)
18.4.12.4. Market Revenue and Forecast, by Solution (2017-2030)
18.4.12.5. Market Revenue and Forecast, by Technology (2017-2030)
18.4.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.4.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.4.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.4.12.9. Market Revenue and Forecast, by Age (2017-2030)
18.4.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.4.12.11. Market Revenue and Forecast, by End User (2017-2030)
18.4.13. North Africa
18.4.13.1. Market Revenue and Forecast, by Type (2017-2030)
18.4.13.2. Market Revenue and Forecast, by Application (2017-2030)
18.4.13.3. Market Revenue and Forecast, by Approach (2017-2030)
18.4.13.4. Market Revenue and Forecast, by Solution (2017-2030)
18.4.13.5. Market Revenue and Forecast, by Technology (2017-2030)
18.4.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.4.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.4.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.4.13.9. Market Revenue and Forecast, by Age (2017-2030)
18.4.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.4.13.11. Market Revenue and Forecast, by End User (2017-2030)
18.4.14. South Africa
18.4.14.1. Market Revenue and Forecast, by Type (2017-2030)
18.4.14.2. Market Revenue and Forecast, by Application (2017-2030)
18.4.14.3. Market Revenue and Forecast, by Approach (2017-2030)
18.4.14.4. Market Revenue and Forecast, by Solution (2017-2030)
18.4.14.5. Market Revenue and Forecast, by Technology (2017-2030)
18.4.14.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.4.14.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.4.14.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.4.14.9. Market Revenue and Forecast, by Age (2017-2030)
18.4.14.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.4.14.11. Market Revenue and Forecast, by End User (2017-2030)
18.4.15. Rest of MEA
18.4.15.1. Market Revenue and Forecast, by Type (2017-2030)
18.4.15.2. Market Revenue and Forecast, by Application (2017-2030)
18.4.15.3. Market Revenue and Forecast, by Approach (2017-2030)
18.4.15.4. Market Revenue and Forecast, by Solution (2017-2030)
18.4.15.5. Market Revenue and Forecast, by Technology (2017-2030)
18.4.15.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.4.15.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.4.15.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.4.15.9. Market Revenue and Forecast, by Age (2017-2030)
18.4.15.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.4.15.11. Market Revenue and Forecast, by End User (2017-2030)
18.5. Latin America
18.5.1. Market Revenue and Forecast, by Type (2017-2030)
18.5.2. Market Revenue and Forecast, by Application (2017-2030)
18.5.3. Market Revenue and Forecast, by Approach (2017-2030)
18.5.4. Market Revenue and Forecast, by Solution (2017-2030)
18.5.5. Market Revenue and Forecast, by Technology (2017-2030)
18.5.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.5.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.5.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.5.9. Market Revenue and Forecast, by Age (2017-2030)
18.5.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.5.11. Market Revenue and Forecast, by End User (2017-2030)
18.5.12. Brazil
18.5.12.1. Market Revenue and Forecast, by Type (2017-2030)
18.5.12.2. Market Revenue and Forecast, by Application (2017-2030)
18.5.12.3. Market Revenue and Forecast, by Approach (2017-2030)
18.5.12.4. Market Revenue and Forecast, by Solution (2017-2030)
18.5.12.5. Market Revenue and Forecast, by Technology (2017-2030)
18.5.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.5.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.5.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.5.12.9. Market Revenue and Forecast, by Age (2017-2030)
18.5.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.5.12.11. Market Revenue and Forecast, by End User (2017-2030)
18.5.13. Rest of LATAM
18.5.13.1. Market Revenue and Forecast, by Type (2017-2030)
18.5.13.2. Market Revenue and Forecast, by Application (2017-2030)
18.5.13.3. Market Revenue and Forecast, by Approach (2017-2030)
18.5.13.4. Market Revenue and Forecast, by Solution (2017-2030)
18.5.13.5. Market Revenue and Forecast, by Technology (2017-2030)
18.5.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)
18.5.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)
18.5.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)
18.5.13.9. Market Revenue and Forecast, by Age (2017-2030)
18.5.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
18.5.13.11. Market Revenue and Forecast, by End User (2017-2030)
Chapter 19. Company Profiles
19.1. F-Hoffman La-Rcohe Ltd. (Switzerland)
19.1.1. Company Overview
19.1.2. Product Offerings
19.1.3. Financial Performance
19.1.4. Recent Initiatives
19.2. Danaher (US)
19.2.1. Company Overview
19.2.2. Product Offerings
19.2.3. Financial Performance
19.2.4. Recent Initiatives
19.3. BD (US)
19.3.1. Company Overview
19.3.2. Product Offerings
19.3.3. Financial Performance
19.3.4. Recent Initiatives
19.4. Thermo Fisher Scientific Inc. (US)
19.4.1. Company Overview
19.4.2. Product Offerings
19.4.3. Financial Performance
19.4.4. Recent Initiatives
19.5. ACON Laboratories Inc. (US)
19.5.1. Company Overview
19.5.2. Product Offerings
19.5.3. Financial Performance
19.5.4. Recent Initiatives
19.6. Hemosure, Inc. (US)
19.6.1. Company Overview
19.6.2. Product Offerings
19.6.3. Financial Performance
19.6.4. Recent Initiatives
19.7. MicroGen Diagnostics (US)
19.7.1. Company Overview
19.7.2. Product Offerings
19.7.3. Financial Performance
19.7.4. Recent Initiatives
19.8. Grifols, S.A (Spain)
19.8.1. Company Overview
19.8.2. Product Offerings
19.8.3. Financial Performance
19.8.4. Recent Initiatives
19.9. BODITECH MED INC. (South Korea)
19.9.1. Company Overview
19.9.2. Product Offerings
19.9.3. Financial Performance
19.9.4. Recent Initiatives
19.10. Chembio Diagnostic Systems, Inc. (US)
19.10.1. Company Overview
19.10.2. Product Offerings
19.10.3. Financial Performance
19.10.4. Recent Initiatives
Chapter 20. Research Methodology
20.1. Primary Research
20.2. Secondary Research
20.3. Assumptions
Chapter 21. Appendix
21.1. About Us
21.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments